Wasatch Advisors Inc. purchased a new stake in UnitedHealth Group Inc (NYSE:UNH) during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 1,165 shares of the healthcare conglomerate’s stock, valued at approximately $228,000.

Other large investors also recently added to or reduced their stakes in the company. Blue Chip Partners Inc. bought a new stake in shares of UnitedHealth Group during the 2nd quarter valued at $110,000. Bruderman Asset Management LLC bought a new stake in shares of UnitedHealth Group during the 2nd quarter valued at $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. boosted its holdings in shares of UnitedHealth Group by 433.3% during the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after buying an additional 520 shares in the last quarter. BDO Wealth Advisors LLC bought a new stake in shares of UnitedHealth Group during the 2nd quarter valued at $121,000. Finally, Acrospire Investment Management LLC boosted its holdings in shares of UnitedHealth Group by 130.7% during the 2nd quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock valued at $131,000 after buying an additional 400 shares in the last quarter. Institutional investors and hedge funds own 86.11% of the company’s stock.

UnitedHealth Group Inc (UNH) opened at $243.35 on Monday. UnitedHealth Group Inc has a 52 week low of $156.49 and a 52 week high of $244.35. The company has a quick ratio of 0.70, a current ratio of 0.73 and a debt-to-equity ratio of 0.58. The firm has a market capitalization of $235,822.58, a P/E ratio of 22.72, a price-to-earnings-growth ratio of 1.42 and a beta of 0.66.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.50 by $0.09. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The business had revenue of $52.06 billion during the quarter, compared to the consensus estimate of $51.57 billion. During the same period in the prior year, the company posted $2.11 EPS. The firm’s revenue for the quarter was up 9.5% compared to the same quarter last year. equities analysts anticipate that UnitedHealth Group Inc will post 12.52 earnings per share for the current fiscal year.

A number of analysts have recently commented on UNH shares. Bank of America boosted their target price on shares of UnitedHealth Group from $230.00 to $240.00 and gave the company a “buy” rating in a report on Wednesday, October 18th. Citigroup upped their price target on shares of UnitedHealth Group from $213.00 to $235.00 and gave the company a “buy” rating in a research report on Wednesday, October 18th. Leerink Swann reaffirmed a “buy” rating and set a $240.00 price target (up previously from $225.00) on shares of UnitedHealth Group in a research report on Wednesday, October 18th. Cantor Fitzgerald reaffirmed a “buy” rating and set a $208.00 price target on shares of UnitedHealth Group in a research report on Tuesday, October 17th. Finally, Jefferies Group upped their price target on shares of UnitedHealth Group from $215.00 to $225.00 and gave the company a “buy” rating in a research report on Friday, October 13th. Two investment analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the company. UnitedHealth Group currently has a consensus rating of “Buy” and an average price target of $243.22.

In other news, Director Gail R. Wilensky sold 5,600 shares of the stock in a transaction that occurred on Wednesday, November 29th. The stock was sold at an average price of $223.31, for a total transaction of $1,250,536.00. Following the completion of the transaction, the director now directly owns 61,137 shares in the company, valued at approximately $13,652,503.47. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Larry C. Renfro sold 22,598 shares of the stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $221.75, for a total value of $5,011,106.50. Following the transaction, the chief executive officer now owns 195,314 shares of the company’s stock, valued at $43,310,879.50. The disclosure for this sale can be found here. Insiders sold a total of 33,655 shares of company stock valued at $7,469,083 over the last 90 days. 0.89% of the stock is currently owned by corporate insiders.

WARNING: “Wasatch Advisors Inc. Purchases Shares of 1,165 UnitedHealth Group Inc (UNH)” was originally posted by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this piece of content on another website, it was illegally copied and republished in violation of United States and international trademark & copyright law. The original version of this piece of content can be read at https://theolympiareport.com/2018/01/22/wasatch-advisors-inc-purchases-shares-of-1165-unitedhealth-group-inc-unh.html.

UnitedHealth Group Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.